Takeda Pharmaceutical Company Limited
NYSE:TAK · New York Stock Exchange
+$0.18 today
Vol 2.05M · Avg 3.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+10.38%
Period High
$18.77
Period Low
$13.01
Latest
$15.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cardinal Health, Inc.
NYSE:CAH
$52.27B
Becton, Dickinson and Company
NYSE:BDX
$52.17B
Edwards Lifesciences Corporation
NYSE:EW
$50.20B
Haleon plc
NYSE:HLN
$39.49B
Agilent Technologies, Inc.
NYSE:A
$35.96B
Alcon Inc.
NYSE:ALC
$31.49B
IQVIA Holdings Inc.
NYSE:IQV
$27.93B
ResMed Inc.
NYSE:RMD
$27.22B
Veeva Systems Inc.
NYSE:VEEV
$24.76B
Insmed Incorporated
NASDAQ:INSM
$20.55B
What is the latest TAK filing?
The latest filing shown is IRANNOTICE dated Jun 17, 2026.
How many recent filings does TAK have?
Intrinsic Alpha currently shows 20 recent filings for TAK.
Explore More
Continue the stock analysis
Jump to another research area for this company.